Dr. Lastra is a surgical pathologist and cytopathologist with subspecialty focus in gynecologic pathology.
The Johns Hopkins Hospital
Advanced Specialty Training Program - Gynecologic Pathology
2015
Hospital of the University of Pennsylvania
Fellowship - Cytopathology
2014
Hospital of the University of Pennsylvania
Fellowship - Surgical Pathology
2013
Pennsylvania Hospital
Residency - Anatomic and Clinical Pathology
2012
Universidad Central de Venezuela
MD
2005
Molecular and Clinicopathologic Characterization of HER2-overexpressed Squamous Cell Carcinoma of the Cervix.
Molecular and Clinicopathologic Characterization of HER2-overexpressed Squamous Cell Carcinoma of the Cervix. Int J Gynecol Pathol. 2024 Oct 31.
PMID: 39480104
Presence and extent of lymphovascular invasion in surgical stage I squamous cell carcinoma of the cervix: a comprehensive, international, multicentre, retrospective clinicopathological study.
Presence and extent of lymphovascular invasion in surgical stage I squamous cell carcinoma of the cervix: a comprehensive, international, multicentre, retrospective clinicopathological study. Pathology. 2024 Sep 30.
PMID: 39477763
Cervical squamous cell carcinoma outcomes across continents: A retrospective study.
Cervical squamous cell carcinoma outcomes across continents: A retrospective study. Gynecol Oncol. 2024 Nov; 190:272-282.
PMID: 39265465
Unraveling the Role of Bromodomain and Extra-Terminal Proteins in Human Uterine Leiomyosarcoma.
Unraveling the Role of Bromodomain and Extra-Terminal Proteins in Human Uterine Leiomyosarcoma. Cells. 2024 Aug 28; 13(17).
PMID: 39273015
Fate of nondiagnostic thyroid fine needle aspirations.
Fate of nondiagnostic thyroid fine needle aspirations. Diagn Cytopathol. 2024 Dec; 52(12):709-714.
PMID: 39051543
Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX models.
Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX models. J Gynecol Oncol. 2024 Jun 14.
PMID: 38909640
Glucocorticoid Receptor (GR) Activation Is Associated with Increased cAMP/PKA Signaling in Castration-Resistant Prostate Cancer.
Glucocorticoid Receptor (GR) Activation Is Associated with Increased cAMP/PKA Signaling in Castration-Resistant Prostate Cancer. Mol Cancer Ther. 2024 Apr 02; 23(4):552-563.
PMID: 38030378
Whole exome sequencing of placental chorangioma.
Whole exome sequencing of placental chorangioma. Placenta. 2024 04; 149:13-17.
PMID: 38484495
Closing the loop - the role of pathologists in digital and computational pathology research.
Closing the loop - the role of pathologists in digital and computational pathology research. J Pathol Clin Res. 2024 Mar; 10(2):e12366.
PMID: 38462794
Glucocorticoid receptor (GR) activation is associated with increased cAMP/PKA signaling in castrate-resistant prostate cancer.
Glucocorticoid receptor (GR) activation is associated with increased cAMP/PKA signaling in castrate-resistant prostate cancer. Mol Cancer Ther. 2023 Nov 30.
PMID: 38030378